News

Today, Scantox, along with its majority owner Impilo, has successfully concluded the acquisition of QPS Neuropharmacology, a leading contract research organization specializing in drug discovery for neurodegenerative diseases,

RemeGen Co. Ltd., a prominent biotechnology company, has recently secured Fast Track Designation from the United States Food and Drug Administration for its innovative drug Telitacicept

Xcell Biosciences Inc. recently expanded its collaboration with Labcorp, a prominent laboratory services provider, by incorporating new elements into their research agreement. In this enhanced partnership

Merz Therapeutics, a subsidiary of the Frankfurt-based Merz, has entered into an agreement to acquire two marketed drugs from the NASDAQ-listed US company Acorda Therapeutics. This deal is expected to significantly contribute to Merz Therapeutics' accelerated growth strategy.

Applied Therapeutics, Inc. has announced an extension in the review period by the U.S. Food and Drug Administration for their New Drug Application for govorestat, intended for treating Classic Galactosemia

Milestone® Pharmaceuticals Inc, a biopharmaceutical company focusing on innovative cardiovascular medicines, has announced the resubmission of its New Drug Application

Renexxion Ireland Limited, in partnership with Dr. Falk Pharma GmbH in Europe, has obtained clearance from the U.S. Food and Drug Administration for its Investigational New Drug application concerning

IntraBio Inc announced today that the U.S. Food and Drug Administration has accepted its New Drug Application for IB1001, intended for treating Niemann-Pick disease Type C. The application

Amneal Pharmaceuticals, Inc. has announced that it received approval for its Abbreviated New Drug Application from the U.S. Food and Drug Administration for ciprofloxacin and dexamethasone

ULTOMIRIS® has recently obtained approval in the United States as the first and only long-acting C5 complement inhibitor for the treatment of adult patients diagnosed with anti-aquaporin-4